| Record ID | ia:cisplatincurrent0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/cisplatincurrent0000unse/cisplatincurrent0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/cisplatincurrent0000unse/cisplatincurrent0000unse_meta.mrc |
LEADER: 01950cam a2200409 i 4500
001 3914544
005 20221027000834.0
008 840411s1980 nyua b 100 0 eng
010 $a 80012220
020 $a0125650507
035 $a(OCoLC)6087538
035 $a(OCoLC)ocm06087538
035 $a(CStRLIN)NYCM84-B935
035 $9ADG6852HS
035 $a(NNC)3914544
035 $a3914544
050 00 $aRC271.C55$bC57
060 0 $aQV290 C579 1979
082 0 $a616.99/4061
245 00 $aCisplatin, current status and new developments /$cedited by Archie W. Prestayko, Stanley T. Crooke, Stephen K. Carter, assisted by Nancy A. Alder.
260 $aNew York :$bAcademic Press,$c1980.
300 $axv, 527 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
500 $aPapers presented at a symposium sponsored by the University of Alabama in Birmingham Comprehensive Cancer Center and the Bristol Laboratories, Syracuse, N.Y., and held Sept. 27-28, 1979, in Atlanta, Ga.
504 $aIncludes bibliographies.
650 0 $aCisplatin$vCongresses.
650 0 $aCancer$xChemotherapy$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2008100047
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
650 2 $aPlatinum$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010984Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aPrestayko, Archie W.$0http://id.loc.gov/authorities/names/n80026431
700 1 $aCrooke, Stanley T.$0http://id.loc.gov/authorities/names/n78072895
700 1 $aCarter, Stephen K.$0http://id.loc.gov/authorities/names/n99025835
710 2 $aUniversity of Alabama in Birmingham.$bComprehensive Cancer Center.$0http://id.loc.gov/authorities/names/n80031573
710 2 $aBristol Laboratories.$0http://id.loc.gov/authorities/names/n80026105
852 00 $boff,hsl$hRC271.C55$iC49 1980